Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
Authors
Keywords
-
Journal
Journal of Nanomaterials
Volume 2013, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2013-11-26
DOI
10.1155/2013/863951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
- (2013) Gang Bao et al. Annual Review of Biomedical Engineering
- Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy
- (2013) Tanmoy Sadhukha et al. BIOMATERIALS
- The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer
- (2013) Jia Zhou et al. BIOMATERIALS
- Polyethylene Glycol-Modified Gelatin/Polylactic Acid Nanoparticles for Enhanced Photodynamic Efficacy of a Hypocrellin Derivative In Vitro
- (2013) Anish Babu et al. Journal of Biomedical Nanotechnology
- Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials
- (2013) Ruibing Wang et al. Journal of Nanomaterials
- Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model
- (2013) Gregory T Wurz et al. Journal of Translational Medicine
- Pulmonary Administration of PEGylated Polylysine Dendrimers: Absorption from the Lung versus Retention within the Lung Is Highly Size-Dependent
- (2013) Gemma M. Ryan et al. MOLECULAR PHARMACEUTICS
- Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model
- (2013) Nour Karra et al. Small
- Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity
- (2013) Amruta Manke et al. Biomed Research International
- Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer
- (2013) Liqin Jiang et al. Nanoscale Research Letters
- Mechanisms of Toxicity of Amorphous Silica Nanoparticles on Human Lung Submucosal Cells in Vitro: Protective Effects of Fisetin
- (2012) Joanna McCarthy et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Polymeric Nanoparticles Containing Taxanes Enhance Chemoradiotherapeutic Efficacy in Non-small Cell Lung Cancer
- (2012) Joohee Jung et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Virus-mediated gene delivery for human gene therapy
- (2012) Mauro Giacca et al. JOURNAL OF CONTROLLED RELEASE
- Liposomal paclitaxel formulations
- (2012) Štěpán Koudelka et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study
- (2012) Dong-mei Yuan et al. Thoracic Cancer
- Optically Traceable Solid Lipid Nanoparticles Loaded with siRNA and Paclitaxel for Synergistic Chemotherapy with In situ Imaging
- (2012) Ki Hyun Bae et al. Advanced Healthcare Materials
- Size-Dependent Photodynamic Activity of Gold Nanoparticles Conjugate of Water Soluble Purpurin-18-N-Methyl-D-Glucamine
- (2012) Byambajav Lkhagvadulam et al. Biomed Research International
- Paclitaxel-Loaded Expansile Nanoparticles Delay Local Recurrence in a Heterotopic Murine Non-Small Cell Lung Cancer Model
- (2011) Rong Liu et al. ANNALS OF THORACIC SURGERY
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
- (2011) Yi-Long Wu et al. BMC CANCER
- Lung cancer: New biological insights and recent therapeutic advances
- (2011) Suresh S. Ramalingam et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lomustine Loaded Chitosan Nanoparticles: Characterization and in-Vitro Cytotoxicity on Human Lung Cancer Cell Line L132
- (2011) Archana Mehrotra et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8+T Cell Responses
- (2011) Lakshmi Krishnan et al. Clinical & Developmental Immunology
- Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
- (2011) Oleh Taratula et al. JOURNAL OF DRUG TARGETING
- Selective Targeting of Antibody Conjugated Multifunctional Nanoclusters (Nanoroses) to Epidermal Growth Factor Receptors in Cancer Cells
- (2011) Li Leo Ma et al. LANGMUIR
- Classification of lung cancer histology by gold nanoparticle sensors
- (2011) Orna Barash et al. Nanomedicine-Nanotechnology Biology and Medicine
- State-of-the-art gene-based therapies: the road ahead
- (2011) Mark A. Kay NATURE REVIEWS GENETICS
- EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells
- (2011) Tomohisa Yokoyama et al. PLoS One
- Nanotoxicology—A Pathologist’s Perspective
- (2011) Ann F. Hubbs et al. TOXICOLOGIC PATHOLOGY
- Diagnostic Detection of Human Lung Cancer-Associated Antigen Using a Gold Nanoparticle-Based Electrochemical Immunosensor
- (2010) Ja-an Annie Ho et al. ANALYTICAL CHEMISTRY
- Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
- (2010) G. P. Stathopoulos et al. ANNALS OF ONCOLOGY
- Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549
- (2010) Rasmus Foldbjerg et al. ARCHIVES OF TOXICOLOGY
- A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions
- (2010) Xianhuo Wang et al. EUROPEAN JOURNAL OF CANCER
- Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer
- (2010) Deling Kong et al. International Journal of Nanomedicine
- ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation
- (2010) Andrew Z Wang et al. Nanomedicine
- The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation
- (2009) Ching-Li Tseng et al. BIOMATERIALS
- Titanium Dioxide Nanoparticles Induce DNA Damage and Genetic Instability In vivo in Mice
- (2009) B. Trouiller et al. CANCER RESEARCH
- Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects
- (2009) Kohei Tahara et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Progress and prospects: immune responses to viral vectors
- (2009) S Nayak et al. GENE THERAPY
- Diagnosing lung cancer in exhaled breath using gold nanoparticles
- (2009) Gang Peng et al. Nature Nanotechnology
- Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy
- (2008) Wei Sun et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Lung-Specific Delivery of Paclitaxel by Chitosan-Modified PLGA Nanoparticles Via Transient Formation of Microaggregates
- (2008) Rui Yang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
- (2008) Marina A. Dobrovolskaia et al. MOLECULAR PHARMACEUTICS
- Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells
- (2007) S CHOI EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started